| Name | Pomstafib-2 |
|---|---|
| Synonyms |
[[2-[bis(2,2-dimethylpropanoyloxymethoxy)phosphoryloxy]-4-[[[2-[4-[(4-phenoxyphenyl)cbamoyl]phenoxy]acetyl]amino]methyl]phenoxy]-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate
((((4-((2-(4-((4-Phenoxyphenyl)cbamoyl)phenoxy)acetamido)methyl)-1,2-phenylene)bis(oxy))bis(oxo-l5-phosphanetriyl))tetrakis(oxy))tetrakis(methylene) tetrakis(2,2-dimethylpropanoate) |
| Description | Pomstafib-2 is a potent and selective STAT5b inhibitor. Pomstafib-2 decreases the expression of pSTAT5b and induces Apoptosis[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Pomstafib-2 (compound 8) (0-10 µM; 4 h) decreases the expression of pSTAT5b in a dose-dependent manner in STAT5b-GFP-transfected K562 cells[1]. Pomstafib-2 (0, 10, 20, 40, 60, 80 µM; 48 h) induces apoptosis in a dose-dependent manner in STAT5-dependent K562 cells[1]. Western Blot Analysis[1] Cell Line: K562 leukaemia cells Concentration: 0, 0.3, 1, 3, 10 µM Incubation Time: 4 h Result: Decreased the expression of pSTAT5b in a dose-dependent manner. Apoptosis Analysis[1] Cell Line: K562, MDA-MB-231 cells Concentration: 0, 10, 20, 40, 60, 80 µM Incubation Time: 48 h Result: Induced apoptosis in a dose-dependent manner in K562 cells, does not increased the apoptotic rate of STAT5-independent MDA-MB-231 cells. |
| References |
| Molecular Formula | C52H66N2O20P2 |
|---|---|
| Molecular Weight | 1101.03 |